Skip to main content
Erschienen in: International Cancer Conference Journal 3/2017

01.07.2017 | Case report

Successful corticosteroid treatment for pleural effusion due to radiation-induced pleuritis after chemoradiotherapy in a patient with esophageal cancer

verfasst von: Takuro Kumagai, Toru Nakano, Haruo Matsushita, Keiichi Jingu, Noriaki Ohuchi, Takashi Kamei

Erschienen in: International Cancer Conference Journal | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Concurrent chemoradiotherapy (CRT) is one of the therapies with curative intent used to treat esophageal squamous cell carcinoma (ESCC), and overall survival of patients with esophageal carcinoma treated with CRT has improved. As the number of long-term survivors treated with concurrent CRT has increased, more patients experience late toxicities. A delayed adverse event, such as pleural effusion, is sometimes fatal, but little is known about its treatment. A 72-year-old man diagnosed with ESCC was treated with definitive CRT. He had a complete response to CRT, and 4 years later he complained of dyspnea, caused by pleural effusion. Diuretic agents and drainage of pleural effusion were not sufficiently effective in this case. After oral administration of 30 mg prednisolone, re-accumulation of fluid in the pleural space was controlled and the prednisolone dose was gradually tapered. Corticosteroids could be effective treatment for delayed pleural effusion after radiotherapy, and should be considered an option for treatment-refractory pleural effusion.
Literatur
1.
Zurück zum Zitat Kumekawa Y, Kaneko K, Ito H et al (2006) Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 41:425–432CrossRefPubMed Kumekawa Y, Kaneko K, Ito H et al (2006) Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol 41:425–432CrossRefPubMed
2.
Zurück zum Zitat Shigematsu N, Kitamura N, Saikawa Y et al (2007) Death related to pleural and pericardial effusions following chemoradiotherapy in a patient with advanced cancers of the esophagus and stomach. Keio J Med 56(4):124–129CrossRefPubMed Shigematsu N, Kitamura N, Saikawa Y et al (2007) Death related to pleural and pericardial effusions following chemoradiotherapy in a patient with advanced cancers of the esophagus and stomach. Keio J Med 56(4):124–129CrossRefPubMed
3.
Zurück zum Zitat Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81(3):684–690CrossRefPubMed Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II–III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81(3):684–690CrossRefPubMed
5.
Zurück zum Zitat Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75(2):348–356CrossRefPubMed Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75(2):348–356CrossRefPubMed
6.
Zurück zum Zitat López RM, Cerezo PL (2007) Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Transl Oncol 9:506–512CrossRef López RM, Cerezo PL (2007) Toxicity associated to radiotherapy treatment in lung cancer patients. Clin Transl Oncol 9:506–512CrossRef
7.
Zurück zum Zitat Yamamoto N, Noda Y, Miyashita Y (2002) A case of refractory bilateral pleural effusion due to post-irradiation constrictive pericarditis. Respirology 7:365–368CrossRefPubMed Yamamoto N, Noda Y, Miyashita Y (2002) A case of refractory bilateral pleural effusion due to post-irradiation constrictive pericarditis. Respirology 7:365–368CrossRefPubMed
8.
Zurück zum Zitat Friedman DL, Constine LS (2006) Late effects of treatment for Hodgkin lymphoma. J Natl Compr Canc Netw 4:249–257CrossRefPubMed Friedman DL, Constine LS (2006) Late effects of treatment for Hodgkin lymphoma. J Natl Compr Canc Netw 4:249–257CrossRefPubMed
9.
Zurück zum Zitat Carver JR, Shapiro CL, Ng A et al (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25:3991–4008CrossRefPubMed Carver JR, Shapiro CL, Ng A et al (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25:3991–4008CrossRefPubMed
10.
Zurück zum Zitat Morota M, Gomi K, Kozuka T et al (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75(1):122–128CrossRefPubMed Morota M, Gomi K, Kozuka T et al (2009) Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 75(1):122–128CrossRefPubMed
11.
Zurück zum Zitat Shirai K, Tamaki Y, Kitamoto Y et al (2011) Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 80(4):1002–1007CrossRefPubMed Shirai K, Tamaki Y, Kitamoto Y et al (2011) Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 80(4):1002–1007CrossRefPubMed
12.
Zurück zum Zitat Vinaya SK, Jyotsna MJ (2012) Pleural effusion: diagnosis, treatment, and management. Emerg Med 4:31–52 Vinaya SK, Jyotsna MJ (2012) Pleural effusion: diagnosis, treatment, and management. Emerg Med 4:31–52
13.
Zurück zum Zitat Marks LB, Yorke ED, Jackson A et al (2010) The use of normal tissue complication probability (NTCP) models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19CrossRefPubMedPubMedCentral Marks LB, Yorke ED, Jackson A et al (2010) The use of normal tissue complication probability (NTCP) models in the clinic. Int J Radiat Oncol Biol Phys 76:S10–S19CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63:5–24CrossRefPubMed Mehta V (2005) Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Int J Radiat Oncol Biol Phys 63:5–24CrossRefPubMed
15.
Zurück zum Zitat American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646–664CrossRef American Thoracic Society (2000) Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161:646–664CrossRef
16.
Zurück zum Zitat William CR, David v, Joseph S et al (1982) Myocardial hydroxyproline reduced by early administration of methylprednisolone of ibuprofen to rabbits with radiation-induced heart disease. Circulation 65(5):924–927CrossRef William CR, David v, Joseph S et al (1982) Myocardial hydroxyproline reduced by early administration of methylprednisolone of ibuprofen to rabbits with radiation-induced heart disease. Circulation 65(5):924–927CrossRef
17.
Zurück zum Zitat Osawa S, Yamada T, Saitoh T et al (2010) Treatment with corticosteroid for pericardial effusion in a patient with advanced synchronous esophageal and gastric cancers following chemoradiotherapy. Case Rep Gastroenterol 4:229–237CrossRefPubMedPubMedCentral Osawa S, Yamada T, Saitoh T et al (2010) Treatment with corticosteroid for pericardial effusion in a patient with advanced synchronous esophageal and gastric cancers following chemoradiotherapy. Case Rep Gastroenterol 4:229–237CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Brian S (1978) Corticosteroids in radiation-induced pericarditis. Chest 74(1):96–98CrossRef Brian S (1978) Corticosteroids in radiation-induced pericarditis. Chest 74(1):96–98CrossRef
19.
Zurück zum Zitat Keelan MH, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med 134:145–147CrossRefPubMed Keelan MH, Rudders RA (1974) Successful treatment of radiation pericarditis with corticosteroids. Arch Intern Med 134:145–147CrossRefPubMed
20.
Zurück zum Zitat Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671CrossRefPubMed Imazio M, Brucato A, Cumetti D et al (2008) Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118:667–671CrossRefPubMed
Metadaten
Titel
Successful corticosteroid treatment for pleural effusion due to radiation-induced pleuritis after chemoradiotherapy in a patient with esophageal cancer
verfasst von
Takuro Kumagai
Toru Nakano
Haruo Matsushita
Keiichi Jingu
Noriaki Ohuchi
Takashi Kamei
Publikationsdatum
01.07.2017
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 3/2017
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-017-0293-y

Weitere Artikel der Ausgabe 3/2017

International Cancer Conference Journal 3/2017 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.